arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

iSpecimen Inc.

ISPC
$1.22 ▼ -0.04 (-3.57%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
27 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
7
Health
Poor
Bearish
auto_awesome

Analytical Summary

iSpecimen Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $1.7M
Dividend Yield —
Revenue Growth -78.7% ↗
Op. Margin None
ROIC -62.0% ↗
FCF / Share $-0.49 ↗
Trailing P/E —
Price / Book 1.1x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

27-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$151.94K
↓ -78.7% —
Net Income Profit after all expenses
$-2.28M
↓ -37.2% —
Operating Margin Operating profit as % of sales
-255.4%
↓ -64.9% 0th
FCF / Share Free cash flow per share
$-0.49
↑ +95.0% —
Long-Term Debt Long-term obligations
$3.43M
— +0.1% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓
0
Financial Health ↓
2
Cash Quality ↓
36

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 7 years · 27 quarters